Skip to content
MARKETS / NYSE / AVD
NYSE · AGRICULTURAL CHEMICALS · MID CAP

American Vanguard Corp. AVD

17 fiscal years on record · USD · FY2025 reported · SEC filings only
$515.1M
▼ 5.9% YoY
$-49.9M
In brief

What this company does

American Vanguard Corporation operates a total of six manufacturing facilities, and at four of them — together with third-party formulators in the U.S. and at various international locations — it synthesizes technical grade active ingredients used in its end-use products and formulates and packages those products, while the other two facilities are biological fermentation sites, one in the U.S. and one in Mexico. AMVAC, a California corporation, is a manufacturer of chemical, biological and biorational products that develops and markets solutions for agricultural, commercial and consumer uses, synthesizing and formulating chemicals and fermenting and extracting microbial products for crops, turf, ornamental plants, and human and animal health protection; these products, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals, are marketed in liquid, powder, and granular forms. The Company has one reportable segment. The Company's largest three customers accounted for 13%, 12%, and 12% of its sales in 2025. The Company employed 739 employees as of December 31, 2025. American Vanguard Corporation was incorporated under the laws of the State of Delaware in January 1969. AMVAC was incorporated under the name of Durham Chemical in August 1945, and its name was subsequently changed to AMVAC in January 1971.

Written from the business description in AMERICAN VANGUARD CORP's annual report to the U.S. Securities and Exchange Commission, filed 16 March 2026. Every sentence was checked against that document before publication.

Growth
USD 515.1M
Revenue, FY2025 · full 17-year series below
Revenue $M Net income $M
FY2025 · Revenue 515.1 · Net income -49.9
250.0M500.0M-50.0M-100.0M200920112013201520172019202120232025
Compound annual growth
−5.5%
+2.3%
+5.9%
+5.6%
−9.1%
−5.6%
−9.9%
+0.0%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +2.3% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
−10 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -5.5% · Net -9.7%
5%10%15%-10%-20%200920112013201520172019202120232025
ROE
FY2019 · ROE 4.1%
5%10%15%-1%-2%-3%200920112013201520172019202120232025

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Net buybacks $M Dividends $M
FY2025 · Dividends 0.0 · Net buybacks 0.0
20MDividendsNet buybacks200920112013201520172019202120232025

Total assetsUSD 596.5M
Gross debtUSD 174.0M
Current ratio1.77×

Not available: we don't have the cash figure for this period.

The 17-year record
17 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
Metric 20252024202320222021202020192018201720162015201420132012201120102009
Revenue $B0.50.50.60.60.60.50.50.50.40.30.30.30.40.40.30.20.2
Operating income $B−0.0−0.10.00.00.00.00.00.00.00.00.00.00.10.10.00.0−0.0
EBITDA $B−0.0−0.10.00.00.00.00.00.00.00.00.00.00.10.10.10.00.0
Income tax $B0.00.00.00.00.00.00.00.00.00.00.0−0.00.00.00.00.0−0.0
Net income $B−0.0−0.10.00.00.00.00.00.00.00.00.00.00.00.00.00.0−0.0
EPS, diluted $−1.75−4.500.260.920.610.510.460.810.680.440.230.171.191.280.790.40−0.21
Dividend / sh $·0.060.120.100.080.040.080.080.060.030.020.170.220.220.080.030.06
Payout %−0−2451013817985171171417107−28
ROE %······4.17.66.94.62.51.914.317.912.56.9−3.8

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 83 reconciliationsAUDITED

Reconciled in 17 of 19 fiscal years. 12 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityAgricultural Chemicals
Listed onNYSE
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2009

Share this section

Download image